ArticleDermatology and therapy2024

Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis.

Peter A Lio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.